Sign In
Buy NRSN
$0.768
-0.0212 (-2.69%)
At Close: Jun 23, 2026
NeuroSense Therapeutics Earnings Calls
Mar 31, 2026
| Release date | Jun 22, 2026 |
| EPS estimate | -$0.0847 |
| EPS actual | - |
| Revenue estimate | 514.1K |
| Revenue actual | - |
Dec 31, 2025
-$0.235 (-231.92%)
| Release date | Apr 06, 2026 |
| EPS estimate | -$0.0708 |
| EPS actual | -$0.235 |
| EPS Surprise | -231.92% |
| Revenue estimate | - |
| Revenue actual | - |
Sep 30, 2025
| Release date | Dec 17, 2025 |
| EPS estimate | - |
| EPS actual | -$0.110 |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2025
-$0.138 (38.14%)
| Release date | Aug 01, 2025 |
| EPS estimate | -$0.223 |
| EPS actual | -$0.138 |
| EPS Surprise | 38.14% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for NeuroSense Therapeutics
Below you can see how NRSN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jun 30, 2025
Beat
| Release date | Aug 01, 2025 |
| Price on release | $1.08 |
| EPS estimate | -$0.223 |
| EPS actual | -$0.138 |
| EPS surprise | 38.14% |
| Date | Price |
|---|---|
| Jul 28, 2025 | $2.03 |
| Jul 29, 2025 | $1.85 |
| Jul 30, 2025 | $1.74 |
| Jul 31, 2025 | $1.80 |
| Aug 01, 2025 | $1.08 |
| Aug 04, 2025 | $1.26 |
| Aug 05, 2025 | $1.38 |
| Aug 06, 2025 | $1.34 |
| Aug 07, 2025 | $1.30 |
| 4 days before | -46.80% |
| 4 days after | 20.37% |
| On release day | 16.67% |
| Change in period | -35.96% |
Sep 30, 2025
| Release date | Dec 17, 2025 |
| Price on release | $0.83 |
| EPS estimate | - |
| EPS actual | -$0.110 |
| Date | Price |
|---|---|
| Dec 11, 2025 | $0.89 |
| Dec 12, 2025 | $0.88 |
| Dec 15, 2025 | $0.84 |
| Dec 16, 2025 | $0.85 |
| Dec 17, 2025 | $0.83 |
| Dec 18, 2025 | $0.82 |
| Dec 19, 2025 | $0.81 |
| Dec 22, 2025 | $0.84 |
| Dec 23, 2025 | $0.84 |
| 4 days before | -6.30% |
| 4 days after | 1.20% |
| On release day | -1.42% |
| Change in period | -5.17% |
Dec 31, 2025
Missed
| Release date | Apr 06, 2026 |
| Price on release | $0.762 |
| EPS estimate | -$0.0708 |
| EPS actual | -$0.235 |
| EPS surprise | -231.92% |
| Date | Price |
|---|---|
| Mar 30, 2026 | $0.731 |
| Mar 31, 2026 | $0.755 |
| Apr 01, 2026 | $0.760 |
| Apr 02, 2026 | $0.83 |
| Apr 06, 2026 | $0.762 |
| Apr 07, 2026 | $0.760 |
| Apr 08, 2026 | $0.721 |
| Apr 09, 2026 | $0.730 |
| Apr 10, 2026 | $0.700 |
| 4 days before | 4.24% |
| 4 days after | -8.14% |
| On release day | -0.262% |
| Change in period | -4.24% |
Mar 31, 2026
| Release date | Jun 22, 2026 |
| Price on release | $0.789 |
| EPS estimate | -$0.0847 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $0.687 |
| Jun 16, 2026 | $0.699 |
| Jun 17, 2026 | $0.705 |
| Jun 18, 2026 | $0.80 |
| Jun 22, 2026 | $0.789 |
| Jun 23, 2026 | $0.768 |
| 4 days before | 14.85% |
| 4 days after | -2.69% |
| On release day | -2.69% |
| Change in period | 11.76% |
NeuroSense Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for NRSN?
NeuroSense Therapeutics Ltd. (NRSN) has scheduled its earnings report for Jun 30, 2026 before the markets open.
What is the NRSN price-to-earnings (P/E) ratio?
NRSN P/E ratio as of Jun 23, 2026 (TTM) is -2.86.
What is the NRSN EPS forecast?
The forecasted EPS (Earnings Per Share) for NeuroSense Therapeutics Ltd. (NRSN) for the first fiscal quarter 2026 is -$0.195.
What are NeuroSense Therapeutics Ltd.'s retained earnings?
On its balance sheet, NeuroSense Therapeutics Ltd. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
